yjanebixe.wordpress.com
The money was granted in collaborationb withthe U.S. Army Medical Research and Materiel Commane and the throughthe Ft. Detrick Technologhy Transfer Initiative. The purpose of the technology transfee program is to raise awarenessx of new and developingt technologies and funding them to transition as viable projectefor follow-on funding in the marketr place. Each company that received funding was awardedapproximateluy $50,000 between March 2008 and May making up the initiative’s second rounsd of financial awards since its $750,000 program The funds for the program’s second phase were secured by Sen. Barbara Mikulski, D-Md., and Rep. Roscoew G. Bartlett, R-Md. “The [Ft.
Detrick Technology Transfer Initiative] program is enabling area businesses to harness the technologie being developed at Fort Detrick and apply them to the commercial said Mikulski. “This will lead to new productsz that have the power to create jobs and save Mikulski announced the first phase of the tech transfer progra in March 2005 when 11 companiesxreceived funding. in Rockville: The companu is developing a health care technology called miTag system, which is a scalable wireless sensof solution for improving patient flow. in The company is developing a technologyy called the GeNova Screento identify, isolate, and producer antibody-like molecules.
in Rockville: The company is developing an on-demans biotech products including a combination vaccin e against plagueand anthrax. BioAssay Works LLC in The company is developinga lateral-flow visual diagnostic test to detect and differentiatw single sample multiple pathogenix poxviruses, including variola, vaccinia, and monkeypox. in The company is safety-testing a medicaol product called ClotFoam, which is a non-compressible, intracavitary hemostatic CynerGene IDMPin Frederick: The companu is developing, validating and implementing a supplemental diagnosisd of Malaria, HIV, and Dengue using its Infectiouw Disease Multiplex Panel approach, which coulr allow for creation of biosensors.
LLC in Baltimore: The company is developinyg required components and system framework to enable conversational interfaces for telemedicine Such tools would allow professional medics touse voice, and other human-- computer interactions to access and document information in electroni c medical records. in Rockville: The company is developingh technology to preserve mammalian celles in dried format that can easilybe re-hydrated for a varietyu of uses. LLC in Frederick: The company is evaluatinv the effect of Imagilin patented probiotics as a food supplement to enhance the immune responsiveness of guinea pigs upon immunization or challenge withvirulent pathogens.
The evaluation will suggestt the ability of Imagilin patented probiotics to enhancre the immunization ofa vaccine. in The company is developinh micropatterned substrates for viralinfectivityt assays. Juxtopia in Baltimore: The compant is customizing its Wearable Assistanc e and SituationalAwareness (WASA) goggles and service to allo w U.S. Army combat medics to accessx and document information to electrical medicalp recordsvia hands-free voice-requests and voice-responses. in The company is developing cell therapies to treat brain and spinaplcord injuries.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment